AstraZeneca's $80 Billion Ambition Just Got A Big Infusion With New Hypertension ResultsInvestors Business Daily • 08/30/25
Polaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca's FluMist® Home Service—The World's First At-Home Nasal Spray Flu VaccineBusiness Wire • 08/21/25
AstraZeneca Rides Oncology Momentum With Blockbuster and New DrugsZacks Investment Research • 08/15/25
The Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global ImpactPRNewsWire • 08/13/25
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomesPRNewsWire • 08/05/25
Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challengesWSJ • 08/01/25
Accelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in GhanaBusiness Wire • 07/30/25
Healthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressureCNBC • 07/30/25
Astrazeneca (AZN) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 07/29/25
AZN Q2 Earnings Meet Estimates, Sales Beat as Key Drugs OutperformZacks Investment Research • 07/29/25